Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

Summary

Lung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer screening among adults who are eligible for screening based on current U.S. Preventive Services Task Force (USPSTF) guidelines. This pilot randomized controlled trial will enroll approximately 80 participants from UC Irvine Health and Emory Healthcare.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Lung Cancer Screening
• Lung Neoplasms
• Smoking ( Cigarette)
• Early Detection of Cancer

Eligibility basics and study details

Study type

Interventional

Phase

Not applicable

Ages

50 to 80 years

Sex

All

Healthy volunteers

Not accepted

Sponsor

University of California, Irvine

Last updated on ClinicalTrials.gov

September 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites